IP Library Patent Application 15369158
Patent Application
App. No. 15/369,158

CANNABIS TABLET OR CAPSULE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/369,158
Abstract

An orally dissolvable cannabis tablet includes one or more active cannabis-based chemical constituents and one or more inactive constituents. The active cannabis-based chemical constituents includes at least one of cannabinoids or terpenoids.

Claims (24)

1 . An orally dissolvable cannabis tablet including one or more active cannabis-based chemical constituents and one or more inactive constituents, the active cannabis-based chemical constituents including at least one of cannabinoids or terpenoids.

2 . The tablet as recited in claim 1 , including 1-100 milligrams of the one or more active cannabis-based chemical constituents and a remainder of the inactive constituents.

3 . The tablet as recited in claim 2 , wherein the tablet has a total weight of 100-1000 milligrams.

4 . The tablet as recited in claim 1 , wherein the one or more active cannabis-based chemical constituents are selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabinol, cannabavarin, cannabigerol, cannabichromene, delta-8-THC, cannabicyclol, cannabitriol, cannabielsoin, myrcene, limonene, and caryophyllene.

5 . The tablet as recited in claim 4 , wherein the one or more active cannabis-based chemical constituents includes multiple active cannabis-based chemical constituents selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabinol, cannabavarin, cannabigerol, cannabichromene, delta-8-THC, cannabicyclol, cannabitriol, cannabielsoin, myrcene, limonene, and caryophyllene.

6 . The tablet as recited in claim 1 , wherein the inactive constituent consists of a predominant amount of a water-soluble solid.

7 . The tablet as recited in claim 6 , wherein the water-soluble solid is selected from the group consisting of starches, sugars, cellulose solids, and combinations thereof.

8 . The tablet as recited in claim 6 , wherein the water-soluble solid is starch.

9 . The tablet as recited in claim 6 , wherein the water-soluble solid is sugar.

10 . The tablet as recited in claim 6 , wherein the water-soluble solid is cellulose.

11 . A machine configured to additively manufacture an orally dissolvable cannabis tablet that includes compositional constituents of one or more active cannabis-based chemical constituents and one or more inactive constituents, the active cannabis-based chemical constituents includes at least one of cannabinoids or terpenoids, the machine including,

one or more cartridges containing one or more of the compositional constituents,

a dispenser connected with the one or more cartridges,

a drive capable of moving the dispenser, and

a controller configured to signal the drive to move the dispenser in accordance with a tablet geometry to dispense the compositional constituents layer-by-layer to form the orally dissolvable cannabis tablet.

12 . The machine as recited in claim 11 , wherein one or more of the compositional constituents are mixed in a carrier fluid in the one or more cartridges.

13 . The machine as recited in claim 11 , wherein the controller is configured to receive one or more data sets that represent a variety of possible selectable geometries of the orally dissolvable cannabis tablet.

14 . The machine as recited in claim 11 , wherein the one or more active cannabis-based chemical constituents are selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabinol, cannabavarin, cannabigerol, cannabichromene, delta-8-THC, cannabicyclol, cannabitriol, cannabielsoin, myrcene, limonene, and caryophyllene.

15 . The machine as recited in claim 11 , wherein the one or more active cannabis-based chemical constituents includes multiple active cannabis-based chemical constituents selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabinol, cannabavarin, cannabigerol, cannabichromene, delta-8-THC, cannabicyclol, cannabitriol, cannabielsoin, myrcene, limonene, and caryophyllene.

16 . The machine as recited in claim 15 , wherein the inactive constituent consists of a predominant amount of a water-soluble solid.

17 . A cannabis tablet or capsule including one or more active cannabis-based chemical constituents and one or more inactive constituents, the active cannabis-based chemical constituents including at least one of cannabinoids or terpenoids.

18 . The tablet or capsule as recited in claim 17 , including 1-150 milligrams of the one or more active cannabis-based chemical constituents and a remainder of the inactive constituents.

19 . The tablet or capsule as recited in claim 17 , including 1-250 milligrams of the one or more active cannabis-based chemical constituents and a remainder of the inactive constituents, and the one or more active cannabis-based chemical constituents include tetrahydrocannabinol, cannabidiol, and cannabinol.

20 . The tablet or capsule as recited in claim 19 , including 1-50 milligrams of the cannabinol.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2021
From: PURE GREEN, LLC
To: PURE GREEN PHARMACEUTICALS, INC.
Reel/Frame 058343/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2020
From: PURE GREEN PHARMACEUTICALS, INC.
To: PURE GREEN, LLC
Reel/Frame 053600/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2020
From: GOLDNER, STEPHEN
To: PURE GREEN PHARMACEUTICALS, INC.
Reel/Frame 052054/0048 →